Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cells

Chemico-Biological Interactions

Volumn 159, Issue 2, 2006, Pages 117-128

  Dvořák, Zdeněk ^a   Vrzal, Radim ^a,b   Maurel, Patrick ^b   Ulrichová, Jitka ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSERM   (France)

Author keywords

Berberine; Chelerythrine; Colchicine; Glucocorticoid receptor; HeLa cells; Nuclear factor kappa B; Sanguinarine

Indexed keywords

ALKALOID; BERBERINE; CHELERYTHRINE; COLCHICINE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; SANGUINARINE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIGAND BINDING; WESTERN BLOTTING;

EID: 29944433944     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.10.105     Document Type: Article

References (31)

1. E. Ben-Chetrit, and M. Levy Colchicine: 1998 update Semin. Arthritis Rheum. 28 1998 48 59
2. R. Bibas, N.K. Gaspar, and M. Ramos-e-Silva Colchicine for dermatologic diseases J. Drugs Dermatol. 4 2005 196 204
3. W.D. Sheng, M.S. Jiddawi, X.Q. Hong, and S.M. Abdulla Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole East Afr. Med. J. 74 1997 283 284
4. N. Sriwilaijareon, S. Petmitr, A. Mutirangura, M. Ponglikitmongkol, and P. Wilairat Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine Parasitol. Int. 51 2002 99 103
5. A.W. Baird, C.T. Taylor, and D.J. Brayden Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of berberine and loperamide in intestinal tissue Adv. Drug Deliv. Rev. 23 1997 111 120
6. K. Fukuda, Y. Hibiya, M. Mutoh, M. Koshiji, S. Akao, and H. Fujiwara Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells J. Ethnopharmacol. 66 1999 227 233
7. C.L. Kuo, C.W. Chi, and T.Y. Liu The anti-inflammatory potential of berberine in vitro and in vivo Cancer Lett. 203 2004 127 137
8. D. Walterova, J. Ulrichova, I. Valka, J. Vicar, C. Vavreckova, E. Taborska, R.J. Harjrader, D.L. Meyer, H. Cerna, and V. Simanek Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications Acta Univ. Palacki. Olomuc. Fac. Med. 139 1995 7 16
9. M.M. Chaturvedi, A. Kumar, B.G. Darnay, G.B. Chainy, S. Agarwal, and B.B. Aggarwal Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation J. Biol. Chem. 272 1997 30129 30134
10. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocr. Rev. 20 1999 435 459
11. K.A. Smoak, and J.A. Cidlowski Mechanisms of glucocorticoid receptor signaling during inflammation Mech. Ageing Dev. 125 2004 697 706
12. I.M. Adcock, and G. Caramori Cross-talk between pro-inflammatory transcription factors and glucocorticoids Immunol. Cell Biol. 79 2001 376 384
13. M. Gottlicher, S. Heck, and P. Herrlich Transcriptional cross-talk, the second mode of steroid hormone receptor action J. Mol. Med. 76 1998 480 489
14. K. De Bosscher, W. Vanden Berghe, and G. Haegeman The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression Endocr. Rev. 24 2003 488 522
15. J. Dostal, E. Taborska, and J. Slavik Preparative column chromatography of quaternary benzophenanthridine alkaloids of Dicranostigma lactucoides Fitoterapia 63 1992 67 70
16. I.W. Southon, and J. Buckingham Dictionary of Alkaloids 1989 Chapman and Hall London
17. J.M. Carcamo, A. Pedraza, O. Borquez-Ojeda, and D.W. Golde Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation Biochemistry 41 2002 12995 13002
18. C.M. Stoscheck Quantitation of protein Methods Enzymol. 182 1990 50 68
19. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
20. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. USA 76 1979 4350 4354
21. A.S. Herr, G.M. Wochnik, M.C. Rosenhagen, F. Holsboer, and T. Rein Rifampicin is not an activator of glucocorticoid receptor Mol. Pharmacol. 57 2000 732 737
22. C. Rosette, and M. Karin Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B J. Cell Biol. 128 1995 1111 1119
23. Z. Dvorak, P. Maurel, J. Ulrichova, and M. Modriansky Microtubule disarray in primary cultures of human hepatocytes inhibits transcriptional activity of the glucocorticoid receptor via activation of c-jun N-terminal kinase Biomed. Pap. Med. Fac. Univ. Palacki. Olomouc. Czech Republ. 148 2004 135 139
24. Z. Dvorak, M. Modriansky, J. Ulrichova, P. Maurel, M.J. Vilarem, and J.M. Pascussi Disruption of microtubules leads to glucocorticoid receptor degradation in HeLa cell line Cell. Signal. 17 2005 187 196
25. W.B. Pratt, M.D. Galigniana, J.M. Harrell, and D.B. DeFranco Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement Cell. Signal. 16 2004 857 872
26. H. Garside, A. Stevens, S. Farrow, C. Normand, B. Houle, A. Berry, B. Maschera, and D. Ray Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain J. Biol. Chem. 279 2004 50050 50059
27. Z. Dvorak, M. Modriansky, L. Pichard-Garcia, P. Balaguer, M.J. Vilarem, J. Ulrichova, P. Maurel, and J.M. Pascussi Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation Mol. Pharmacol. 64 2003 160 169
28. Z. Dvorak, M. Modriansky, J. Ulrichova, and P. Maurel Speculations on the role of the microtubule network in glucocorticoid receptor signaling Cell Biol. Toxicol. 20 2004 333 343
29. Z. Dvorak, J. Ulrichova, and M. Modriansky Role of microtubules network in CYP genes expression Curr. Drug Metab. 2005
30. A. Duvoix, S. Delhalle, R. Blasius, M. Schnekenburger, F. Morceau, M. Fougere, E. Henry, M.M. Galteau, M. Dicato, and M. Diederich Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition Biochem. Pharmacol. 68 2004 1101 1111
31. K. De Bosscher, W. Vanden Berghe, L. Vermeulen, S. Plaisance, E. Boone, and G. Haegeman Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell Proc. Natl. Acad. Sci. USA 97 2000 3919 3924